Trials / Recruiting
RecruitingNCT04871035
Immunoadsorption Versus Plasma Exchange for Treatment of Guillain-Barré Syndrome (GBS)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (estimated)
- Sponsor
- University of Ulm · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an observations study evaluating safety and efficacy of immunoadsorption compared to plasma exchange in Guillain-Barré Syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Immunoadsorption | 1 cycle, consisting of 5 sessions on 5 consecutive days with processing of the 0.7-fold individual plasma volume (maximum 2.5 l) each days with tryptophan adsorbers. |
| DEVICE | Plasma Exchange | 1 cycle, consisting of 5 sessions on 5 consecutive days with exchange of 0.7-fold plasma volume (maximum 2.5 l) each day with albumin solution as volume replacement solution. |
Timeline
- Start date
- 2021-04-28
- Primary completion
- 2025-05-04
- Completion
- 2025-05-04
- First posted
- 2021-05-04
- Last updated
- 2024-05-08
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04871035. Inclusion in this directory is not an endorsement.